Literature DB >> 34621048

New targets in triple-negative breast cancer.

Robert L Copeland1, Yasmine Kanaan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34621048     DOI： 10.1038/s41568-021-00415-4

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells.

Authors:  Anna Wawruszak; Jarogniew Luszczki; Arkadiusz Czerwonka; Estera Okon; Andrzej Stepulak
Journal:  Cells       Date:  2022-04-04       Impact factor: 6.600
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.